Notice of Effectiveness (effect)
08 November 2017 - 10:01PM
Edgar (US Regulatory)
UNITED STATES
|
SECURITIES AND EXCHANGE COMMISSION
|
Washington, D.C. 20549
|
NOTICE OF EFFECTIVENESS
|
|
Effective Date:
|
November 06,
2017 5:30 P.M.
|
Form:
|
S-4
|
CIK:
|
0001390478
|
Company Name:
|
Galena Biopharma, Inc.
|
File Number:
|
333-220592
|
SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart
From Apr 2024 to May 2024
SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart
From May 2023 to May 2024